SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-299374
Filing Date
2014-08-07
Accepted
2014-08-07 06:49:29
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d759218d10q.htm 10-Q 622202
2 EX-10.1 d759218dex101.htm EX-10.1 186199
3 EX-31.1 d759218dex311.htm EX-31.1 6752
4 EX-31.2 d759218dex312.htm EX-31.2 6762
5 EX-32.1 d759218dex321.htm EX-32.1 4330
6 EX-32.2 d759218dex322.htm EX-32.2 4327
  Complete submission text file 0001193125-14-299374.txt   5642197

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT srpt-20140630.xml EX-101.INS 852459
8 XBRL TAXONOMY EXTENSION SCHEMA srpt-20140630.xsd EX-101.SCH 51593
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20140630_cal.xml EX-101.CAL 66158
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20140630_def.xml EX-101.DEF 163827
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20140630_lab.xml EX-101.LAB 396648
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20140630_pre.xml EX-101.PRE 294850
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 141021678
SIC: 2834 Pharmaceutical Preparations